Director Alexander van 't Noordende gains 2,002 AECOM (NYSE: ACM) RSUs

Rhea-AI Filing Summary

van 't Noordende Alexander M reported acquisition or exercise transactions in this Form 4 filing.

AECOM director Alexander M. van 't Noordende received a grant of 2,002 shares of common stock in the form of restricted stock units. These units vest on the earlier of March 3, 2027, or the company’s 2027 annual meeting of stockholders. Following this award, he holds 12,423 shares directly.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

van 't Noordende Alexander M

(Last) (First) (Middle)

C/O AECOM

13355 NOEL RD, SUITE 400

(Street)

DALLAS TX 75240

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
AECOM [ ACM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
03/03/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock(1)	03/03/2026		A		2,002	A	$0	12,423	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents restricted stock units, which vest on the earlier of March 3, 2027, or the date of the Issuer's 2027 Annual Meeting of Stockholders.

Remarks:

	Matt Benson, Attorney-in-Fact for Alexander van 't Noordende	03/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did AECOM (ACM) director Alexander van 't Noordende report on this Form 4?

Alexander M. van 't Noordende reported receiving 2,002 shares of AECOM common stock as a restricted stock unit grant. This award increased his directly held stake to 12,423 shares following the transaction on March 3, 2026.

How many AECOM (ACM) shares were granted to Alexander van 't Noordende?

He was granted 2,002 shares of AECOM common stock in the form of restricted stock units. These units represent equity compensation and are scheduled to vest based on time-based conditions tied to March 3, 2027, or the 2027 annual meeting.

When do Alexander van 't Noordende’s new AECOM restricted stock units vest?

The restricted stock units vest on the earlier of March 3, 2027, or the date of AECOM’s 2027 annual meeting of stockholders. Vesting timing therefore depends on when that shareholder meeting is held relative to March 3, 2027.

What is Alexander van 't Noordende’s AECOM share ownership after this Form 4 transaction?

After the reported grant, Alexander M. van 't Noordende directly holds 12,423 shares of AECOM common stock. This total includes the 2,002 restricted stock units awarded in the March 3, 2026 transaction described in the Form 4 filing.

Was the AECOM (ACM) Form 4 transaction a market purchase or sale?

No, the transaction represents a grant or award of 2,002 restricted stock units, not a market trade. It is coded as an acquisition under transaction code “A,” reflecting equity compensation rather than an open-market buy or sell.

What type of security did Alexander van 't Noordende receive from AECOM?

He received restricted stock units tied to AECOM common stock. These units convert into common shares upon vesting, which occurs on the earlier of March 3, 2027, or the date of AECOM’s 2027 annual meeting of stockholders.